Document is current
Any future updates will be listed below
-
Authors
Mesa-Eguiagaray, Ines https://orcid.org/0000-0002-6784-2419
Wild, Sarah H. https://orcid.org/0000-0001-7824-2569
Williams, Linda J. https://orcid.org/0000-0002-6317-1718
Jin, Kai https://orcid.org/0000-0002-4071-7415
Bird, Sheila M.
Brewster, David H. https://orcid.org/0000-0002-5346-5608
Hall, Peter S. https://orcid.org/0000-0001-6015-7841
Figueroa, Jonine D. https://orcid.org/0000-0002-5100-623X
-
Funding
Funding for this research was provided by:
Wellcome Trust (207800/Z/17/Z)
- License Information
-
More Information
Article History
Received: 15 November 2024
Accepted: 27 March 2025
First Online: 22 April 2025
Declarations
:
: Approval from the Public Benefit and Privacy Panel for Health (PBPP) and Social Care is a requirement for data access. Our project was approved by PBPP reference number 1718-0057.
: Not applicable.
: SMB holds shares in GlaxoSmithKline. Other authors declare no competing interests.
